Caribou Biosciences, Inc.
CRBUNASDAQHealthcare● Active
$1.84
$-0.08(-4.17%)
Market Cap$182492258
P/E Ratio—
52W High$3.535
52W Low$1.04
Caribou Biosciences, Inc. (CRBU) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CRBU · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $11.16M | $9.99M | $34.48M | $13.85M | $9.60M |
| Cost of Revenue | $3.65M | $3.93M | $3.52M | $3.64M | $0.98M |
| Gross Profit | $7.51M | $6.07M | $30.95M | $10.21M | $8.61M |
| Gross Margin %(computed) | 67.34% | 60.71% | 89.78% | 73.71% | 89.75% |
| Operating Expenses | |||||
| R&D Expenses | $109.44M | $130.15M | $112.08M | $82.23M | $52.26M |
| G&A Expenses | $37.91M | $46.46M | $38.46M | $38.02M | $0.00M |
| Total Operating Expenses | $143.71M | $172.68M | $147.01M | $116.61M | $75.59M |
| Operating Income | ($136.19M) | ($166.62M) | ($116.06M) | ($106.40M) | ($66.98M) |
| Operating Margin %(computed) | — | — | -336.63% | -768.17% | -697.84% |
| Interest Income | $8.00M | $0.00M | $10.70M | $4.60M | $0.15M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.01M |
| Income Before Tax | ($148.68M) | ($149.11M) | ($101.88M) | ($99.35M) | ($66.60M) |
| Income Tax Expense | ($0.55M) | ($0.01M) | $0.19M | $0.07M | $0.32M |
| Net Income | ($148.13M) | ($149.10M) | ($102.07M) | ($99.42M) | ($66.92M) |
| Net Margin %(computed) | — | — | -296.05% | -717.79% | -697.26% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-1.11 |
| Wtd Avg Shares | 93.39M | 90.32M | 73.81M | 60.80M | 60.26M |
| EBITDA | ($132.55M) | ($162.69M) | ($112.53M) | ($95.71M) | ($65.61M) |
| EBITDA Margin %(computed) | — | — | -326.40% | -691.00% | -683.58% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Caribou Biosciences, Inc. data
About Caribou Biosciences, Inc. (CRBU) Income Statement
Caribou Biosciences, Inc. (CRBU) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CRBU reported revenue of $0.01B, gross profit of $0.01B (gross margin 67.34%), and net income of ($0.15B) — a net profit margin of -1327.40%.
Frequently asked questions
CRBU · 4 questionsCaribou Biosciences, Inc. (CRBU) reported revenue of $0.01B for 2025, up 11.7% year-over-year.
CRBU revenueCRBU salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09